These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 877408)

  • 21. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
    Sallinen V; Sundvik M; Reenilä I; Peitsaro N; Khrustalyov D; Anichtchik O; Toleikyte G; Kaslin J; Panula P
    J Neurochem; 2009 Apr; 109(2):403-15. PubMed ID: 19222706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the monoamine oxidase inhibiting properties of imidazole derivatives].
    Winter R
    Acta Biol Med Ger; 1973; 30(4):555-61. PubMed ID: 4146878
    [No Abstract]   [Full Text] [Related]  

  • 28. The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamine.
    Yu AM; Granvil CP; Haining RL; Krausz KW; Corchero J; Küpfer A; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2003 Feb; 304(2):539-46. PubMed ID: 12538805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of monoamine oxidase maturation in mouse brain.
    Baker PC; Hoff KM; Samsa JM
    Biol Neonate; 1983; 43(1-2):67-71. PubMed ID: 6850015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histochemical characterization of monoamine oxidase in ependyma of rat hypothalamus.
    Williams D; Gascoigne JE; Street M; Williams ED
    Histochem J; 1979 Jan; 11(1):83-95. PubMed ID: 429200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolism of indole amines in depression.
    Hullin RP
    Postgrad Med J; 1976; 52(3 suppl):18-24. PubMed ID: 785421
    [No Abstract]   [Full Text] [Related]  

  • 34. An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    J Neurochem; 1962; 9():299-306. PubMed ID: 13888045
    [No Abstract]   [Full Text] [Related]  

  • 35. Procaine hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric therapy.
    Fuller RW; Roush BW
    J Am Geriatr Soc; 1977 Feb; 25(2):90-3. PubMed ID: 833415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo-inhibition of serotonin synthesis in mouse brain by beta-phenylethylhydrazine, an inhibitor of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    Biochem Pharmacol; 1962 Jan; 11():45-52. PubMed ID: 13888046
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple forms of monoamine oxidase in rabbit platelets.
    Edwards DJ; Chang SS
    Life Sci; 1975 Oct; 17(7):1127-34. PubMed ID: 1196003
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.
    White HL; Glassman AT
    J Neurochem; 1977 Dec; 29(6):987-97. PubMed ID: 599351
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of brain 5-HT neurons by two alpha-methylated tryptamine derivatives.
    Arai Y; Tadano T; Yonezawa A; Fujita T; Kinemuchi H; Kisara K
    Prog Brain Res; 1995; 106():269-75. PubMed ID: 8584663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.